Fundraising FoxTurn Biotechnologies, Inc.
Mountain View, US · Founded 2018 · Delaware corporation · 4 known investors
Find your way into Turn Biotechnologies, Inc.
Sign up to see every warm intro you have to Turn Biotechnologies, Inc.
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Turn Biotechnologies, Inc. team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
mRNA/LNP based in vivo cell rejuvenation
Founders & leadership
Turn Biotechnologies, Inc. was founded in 2018 by Vittorio Sebastiano, Marco Quarta, and Anja Krammer.
VS
Vittorio SebastianoCo-founder
MQ
Marco QuartaCo-founder
AK
Anja KrammerCo-founder
SA
Sergio Andres Ruiz-ChinchillaNamed on SEC filing
RP
Ric PetersonNamed on SEC filing
Board
DG
David GobelBoard director
Investors · 4
Astellas Venture Management LLClisted by Astellas Venture Management LLCSouth San Francisco · $200K – $5M
How we know: Astellas Venture Management LLC's portfolio page · Not right? Tell us
Formic VenturesreportedSan Francisco
How we know: press coverage · Not right? Tell us
Khosla VenturesreportedMenlo Park · $100K – $20M
How we know: press coverage · Not right? Tell us
Shanda GroupreportedRedwood City
How we know: press coverage · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$29.1M disclosed across 1 round · 2023
▶$29.1MraisedSep 2023 · 55 investors · OtherRule 506(b)
▶$29.1MraisedSep 2023 · 55 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Vittorio SebastianoDirector
- Marco QuartaDirector
- Sergio Andres Ruiz-ChinchillaExecutive Officer
- David GobelDirector
- Anja KrammerExecutive Officer, Director
- Ric PetersonExecutive Officer
- Offering amount
- $43.9M
- Amount sold
- $29.1M
- First sale
- Aug 2023
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Turn Biotechnologies, Inc. do?
- mRNA/LNP based in vivo cell rejuvenation
- Who founded Turn Biotechnologies, Inc.?
- Turn Biotechnologies, Inc. was founded by Vittorio Sebastiano, Marco Quarta, Anja Krammer in 2018.
- Who are Turn Biotechnologies, Inc.'s investors?
- Turn Biotechnologies, Inc.'s investors include Astellas Venture Management LLC, Formic Ventures, Khosla Ventures, Shanda Group.
- How much funding has Turn Biotechnologies, Inc. raised?
- Turn Biotechnologies, Inc. has disclosed $29.1M raised across 1 round.
- Where is Turn Biotechnologies, Inc. headquartered?
- Turn Biotechnologies, Inc. is headquartered in Mountain View, US.